ENXTPA:ERFLife Sciences
Assessing Eurofins Scientific (ENXTPA:ERF) Valuation After Alphora’s New AI Drug Development Platform Launch
Eurofins Scientific (ENXTPA:ERF) is back in focus after subsidiary CDMO Alphora launched an AI-powered platform for high throughput salt and co-crystal screening, targeting faster, lower cost decisions in drug substance solid form development.
See our latest analysis for Eurofins Scientific.
The AI platform launch sits alongside share repurchases and recent insider share acquisitions. It comes as Eurofins Scientific’s share price has a 30 day return of 14.64% and a year to date share price...